期刊文献+

同种异体单肺移植治疗终末期肺气肿一例

下载PDF
导出
摘要 目的探讨单肺移植术治疗终末期肺气肿患者的疗效,总结围术期处理的经验。方法2004年6月对1例终末期肺气肿患者行左侧单肺移植术,术后给予他克莫司(FK506)、骁悉(MMF)和甲基强的松龙(1周后改为强的松)三联方案进行免疫抑制治疗。结果术后呼吸机辅助呼吸92h,术后第4d发生排斥反应,经FK506、MMF和甲基强的松龙(1周后改为强的松)三联免疫抑制治疗,症状明显改善。术后6个月复查动脉血氧分压(PaO2)为78mmHg(不吸氧),6min步行试验130m(不吸氧);生活可完全自理,能从事轻度的体力劳动,现已生存2年3个月。结论肺移植是治疗终末期肺气肿的有效手段之一。
出处 《中国胸心血管外科临床杂志》 CAS 2007年第2期139-140,共2页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
  • 相关文献

参考文献10

  • 1Hosenpud JD,Bennett LE,Keck BM,et al.The registry of the international society for heart and lung transplantation:eighteenth official report-2001.J Heart Lung Transplant,2001,20(8):805-815.
  • 2Taylor DO,Edwards LB,Boucek MM,et al.Registry of the international society for heart and lung transplantation:twenty second official adult heart transplant report-2005.J Heart Lung Transplant,2005,24 (8):945-955.
  • 3Cooper JD.Lung transplantation.In:Baue AE,Geha AS.Gler's Thoracic and Cardiovascular Surgery.15th ed.USA:Appleton & Lange Co.,1990.1447-1449.
  • 4Schulman LL,Weinberg AD,McGregor C,et al.Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.Am J Respir Crit Care Med,1998,157(6 Pt 1):1833-1837.
  • 5胡春晓,朱艳红,陈静瑜,蹇英,郑明峰,何毅军.机械通气在肺移植术后的临床应用——附5例临床报道[J].中国急救医学,2004,24(6):468-468. 被引量:9
  • 6Singh N,Husain S.Aspergillus infections after lung transplantation:clinical differences in type of transplant and implications for management.J Heart Lung Transplant,2003,22(3):258-266.
  • 7陈静瑜,何毅军,郑明峰,朱乾坤,陈若,王永功,刘峰,朱艳红.单肺移植治疗终末期肺气肿三例[J].中国胸心血管外科临床杂志,2005,12(3):198-199. 被引量:8
  • 8梁朝阳,刘德若.免疫抑制剂在肺移植中的应用进展[J].北京医学,2006,28(3):169-172. 被引量:3
  • 9Wiland AM,Philosophe B.Daclizumab induction in solid organ transplantation.Expert Opin Biol Ther,2004,4(5):729-740.
  • 10姜格宁,丁嘉安,高文,张雷,朱余明,汪浩,周晓,谢博雄,陈昶,李文涛,杨健.单肺移植术治疗重度肺气肿[J].中华胸心血管外科杂志,2005,21(6):321-324. 被引量:8

二级参考文献20

  • 1张璟,洪志鹏.肺移植的研究进展[J].医学综述,2004,10(7):431-433. 被引量:8
  • 2孙衍庆.现代胸心外科学[M].北京:人民军医出版社,2000.1064-1094.
  • 3Hertz MI, Iaylov PO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: nineteenth official report -2002. J Heart Lung Transplant, 2003,1:950-970.
  • 4Trulock EP, Edwards LB, Tayor DO, et al. The registry of the international society for heart and lung transplantation: twentieth official adult lung and heart-lung transplant report -2003. J Heart Lung Transplant, 2003,22:625-635.
  • 5Meyer DM, Bennett LE, Novick RJ, et al. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart and Lung Transplant, 2001,20:935-941.
  • 6Schafers HJ, Haydock DA, Cooper JD. The prevalence and management of bronchial anastomotic complications in lung transplantation. J Thorac Cardiorasc Surg, 1999,101:1044-1052.
  • 7Herrera JM, McNeil KD, Higgins RS, et al. Airway complications after lung transplantation: treat long-term outcome. Ann Thorac Surg, 2001,71:989-993.
  • 8Haydock DA, Trulock EP, Kaiser LR, et al. Lung transplantation. Analysis of thirty-six consective procedures performed over a twelve-month period. J Thorac Cardiovasc Surg, 1992,103:329-340.
  • 9Minari A, Husni R, Avery RK, et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxi lung transplants. Transpl Infect Dis,2002,4:195-200.
  • 10De Pablo A, Ussetti P, Cruz Carreno M, et al. Aspergillosis in pulmonary transplantation. Enferm Infect Microbiol Clin, 2000,18:209-214.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部